RF-014Original text reviewed

Heavy phone use categories in CERENAT

The reported finding

In the >=896-h recalled cumulative-call category, adjusted ORs were 2.89 (95% CI 1.41-5.93) for glioma (24 cases/22 controls in category) and 2.57 (1.02-6.44) for meningioma (13/9). Regular use overall was not significantly associated with either tumour.

Reading it carefully

Retrospective case-control association, with recall/selection bias, proxy interviews, small extreme-use cells and multiple analyses. Call duration is not absorbed dose; no harmful SAR threshold follows. Main Table 3 estimates are distinct from later laterality recalculations.

Inside the study

Exposure conditions
Recalled mobile-phone use; regular use >=one call weekly for >=six months. Main analyses exclude use in the year before diagnosis; categories based on control distribution, highest >=90th percentile.
Design & controls
France 2004-2006; 253 gliomas, 194 meningiomas, 892 matched controls. Conditional logistic models: glioma adjusted for education and ionising radiation; meningioma for education. Exposure-variable sample sizes vary.
The protection question raised
Does the heavy-use association reflect a real cancer risk or biases in recalled use and participation? It raises a long-term exposure question without converting reported call time into absorbed dose.
Source verification
Original article PDF methods, Tables 2-4 and disclosures reviewed; journal final metadata verified
Where to find the result
Original online-first PDF pp.2-3 methods; p.5 Table 3 with covariates; p.6 Table 4; p.8 funding
Editorial notices
No formal retraction/concern located in Scite and targeted publisher/DOI search. Author response DOI 10.1136/oemed-2014-102649 revisits laterality analysis; no revised laterality estimate is used here.
Funding
Fondation de France; AFSSET; Association pour la Recherche contre le Cancer; Ligue contre le Cancer; INSERM ATC Environnement et Sante.
Conflicts of interest
Authors state none.

Original publication

Coureau G, Bouvier G, Lebailly P, Fabbro-Peray P, Gruber A, Leffondre K, Guillamo JS, Loiseau H, Mathoulin-Pélissier S, Salamon R, Baldi I. Mobile phone use and brain tumours in the CERENAT case-control study. Occupational and Environmental Medicine. 2014;71(7):514-522. doi:10.1136/oemed-2013-101754.